Introduction
DABIGATREX 150 is a highly effective oral anticoagulant formulated with Dabigatran Etexilate Mesylate 150 mg. This medicine belongs to the class of direct thrombin inhibitors and is widely used for the prevention and treatment of thromboembolic disorders. Dabigatran works by directly blocking thrombin, the key enzyme responsible for blood clot formation, thus reducing the risk of stroke and systemic embolism.Also available as dabigatran etexilate mesilate capsules 150 mg, this medication is recognized for its predictable pharmacological action, reduced need for monitoring compared to traditional anticoagulants, and strong clinical evidence supporting its use.
Mechanism of Action
Dabigatran Etexilate is a prodrug that is rapidly converted in the body to dabigatran, its active form. Dabigatran acts as a direct thrombin inhibitor, binding to both free and clot-bound thrombin, thereby preventing the conversion of fibrinogen to fibrin — the final step in clot formation. This action helps in preventing the development and extension of harmful blood clots in the blood vessels.
Uses and Indications
DABIGATREX 150 is indicated for:
Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Reduction in the risk of recurrence of DVT and PE.
Post-operative thromboprophylaxis in patients undergoing hip or knee replacement surgery.
Efficacy and Clinical Evidence
Extensive clinical studies, including the RE-LY and RE-COVER trials, have established the efficacy of dabigatran etexilate in reducing the risk of stroke in atrial fibrillation and in managing venous thromboembolism.
Key benefits observed:
Comparable or superior effectiveness to warfarin in preventing thromboembolic events.
Lower rates of intracranial hemorrhage compared to vitamin K antagonists.
Predictable anticoagulant effect without the need for frequent INR monitoring.
Side Effects and Safety Profile
Common side effects:
Gastrointestinal discomfort (indigestion, abdominal pain)
Nausea
Minor bleeding (nosebleeds, gum bleeding)
Easy bruising
Serious but less common side effects:
Major bleeding events
Allergic reactions (rash, swelling, difficulty breathing)
Liver function abnormalities
Contraindications and Precautions
Do not use DABIGATREX 150 in:
Patients with active pathological bleeding
Severe renal impairment (CrCl < 30 mL/min)
History of hypersensitivity to dabigatran etexilate mesylate
Precautions:
Use with caution in patients with increased bleeding risk
Dose adjustments may be required in moderate kidney impairment
Monitor closely if undergoing surgery or invasive procedures
Drug Interactions
dabigatran etexilate mesilate capsules 150 mg may interact with:
P-glycoprotein inhibitors (e.g., amiodarone, verapamil) – may increase dabigatran levels
P-glycoprotein inducers (e.g., rifampin) – may reduce effectiveness
Other anticoagulants or antiplatelet agents – increased bleeding risk
Non-steroidal anti-inflammatory drugs (NSAIDs)
Warnings and Regulatory Status
Approved by major health authorities including USFDA and EMA for specific indications.
Not interchangeable with other anticoagulants without medical supervision.
Always follow physician guidance to avoid under- or over-anticoagulation.
Patient Advice and Tips
Take the capsule whole with a glass of water; do not chew or open.
Maintain consistent dosing times.
Inform your doctor before any surgery or dental procedure.
Immediately report unusual bleeding or bruising.
Do not stop treatment abruptly without consulting a healthcare provider.
Availability
DABIGATREX 150 is manufactured by Steris Healthcare Pvt Ltd, available in blister packs for convenient dosing. It is distributed pan-India through a wide pharmaceutical network, ensuring timely availability to patients.
Frequently Asked Questions
1. What is dabigatran etexilate used for?
It is used to prevent stroke in patients with atrial fibrillation, and to treat or prevent deep vein thrombosis and pulmonary embolism.
2. How does DABIGATREX 150 differ from warfarin?
It offers predictable anticoagulant action, fewer food/drug interactions, and does not require frequent INR monitoring.
3. Can I take dabigatran etexilate with food?
Yes, it can be taken with or without food.
4. Why choose Steris Healthcare Pvt Ltd for DABIGATREX 150?
Steris Healthcare ensures WHO-GMP certified manufacturing, strict quality control, affordable pricing, and wide accessibility across India.
5. What should I do if I miss a dose?
Take it as soon as you remember on the same day, but skip it if it's close to your next scheduled dose. Never double dose.
Conclusion
DABIGATREX 150, containing Dabigatran Etexilate Mesylate, represents a modern, effective, and safer alternative to traditional anticoagulants for preventing and treating thromboembolic disorders. With robust clinical backing, predictable dosing, and quality manufacturing by Steris Healthcare Pvt Ltd, it is a trusted choice for doctors and patients seeking optimal anticoagulant therapy.
